Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Total Non-Current Liabilities: 2011-2019

Historic Total Non-Current Liabilities for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Mar 2019 value amounting to $59.9 million.

  • EyePoint Pharmaceuticals' Total Non-Current Liabilities rose 71.06% to $59.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was $59.9 million, marking a year-over-year increase of 71.06%. This contributed to the annual value of $40.2 million for FY2018, which is 659.98% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Total Non-Current Liabilities of $59.9 million as of Q1 2019, which was up 53.22% from $39.1 million recorded in Q4 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Total Non-Current Liabilities ranged from a high of $59.9 million in Q1 2019 and a low of $5.3 million during Q2 2017.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Total Non-Current Liabilities value was $39.5 million (recorded in 2018), while the average stood at $36.6 million.
  • Data for EyePoint Pharmaceuticals' Total Non-Current Liabilities shows a peak YoY skyrocketed of 659.98% (in 2018) over the last 5 years.
  • Over the past 3 years, EyePoint Pharmaceuticals' Total Non-Current Liabilities (Quarterly) stood at $5.3 million in 2017, then surged by 659.98% to $39.1 million in 2018, then surged by 71.06% to $59.9 million in 2019.
  • Its Total Non-Current Liabilities stands at $59.9 million for Q1 2019, versus $39.1 million for Q4 2018 and $39.9 million for Q3 2018.